- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05655429
Physical Therapy vs Arthroscopic Partial Meniscectomy
March 11, 2023 updated by: Shenzhen People's Hospital
Physical Therapy vs Arthroscopic Partial Meniscectomy on the Knee Function of Metabolic Syndrome Patients With Degenerative Meniscus Lesions
The purpose was to assess knee function outcomes between physical therapy and arthroscopic partial menisectomy(APM) for Metabolic syndrome(MetS) patients with degenerative meniscus lesions(DMLs) during 12 month follow up.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Metabolic syndrome were diagnosed with abdominal obesity, insulin resistance with or without glucose intolerance, dyslipidemia or elevated blood pressure and widely prevalence all around the world.MetS patients were always correlated with knee osteoarthritis or cartilage volume loss.
For MetS patients with DMLs, whether physical therapy was non-inferior to APM in knee function and MetS components was unknown.
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hongyu Wang, Doctor
- Phone Number: 18241651300
- Email: wanghongyu790039663@126.com
Study Locations
-
-
Guangdong
-
Shenzhen, Guangdong, China, 121000
- Recruiting
- ShenZhen People's Hospital
-
Contact:
- Yu Luo, Master
- Phone Number: 18841609587
- Email: zhzm622@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Must be age between 35 and 70 years old;
- Clinical diagnosis of metabolic syndrome;
- Clinical diagnosis of degenerative meniscus lesions;
- Patients who has knee pain history
- Knee symptoms consistent with DMLs verified on MRI
- eligible for arthroscopic partial meniscectomy surgery by the examining orthopedic surgeons.
Exclusion Criteria:
Must be able to have no acute knee injury such as car crash or acute sports injury;
- Must be able to have no knee surgeries history;
- Must be able to have no rheumatoid arthritis or serious knee osteoarthritis with deformity;
- Must be able to have no contraindications to MRI;
- Must be able to have no severe cardiopulmonary disease;
- Must be able to have no musculoskeletal or neuromuscular impairments ;
- Must be able to have good visual, hearing, or cognitive;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: physical therapy
Physical therapy mainly include aerobic exercises and resistance exercise, flexibility exercises about 150 minutes for ≥2 d/week for 6 months.
|
The exercise intervention included aerobic exercises and resistance exercise, flexibility exercises about 150 minutes for ≥2 day per week.
|
Active Comparator: arthroscopic partial meniscectomy
The torn meniscus and unstable part were removed with arthroscopic instruments.
|
Arthroscopic partial meniscectomy surgery procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the Knee Injury and Osteoarthritis Outcome Score (KOOS) change
Time Frame: change from baseline up to 12 months
|
The Knee injury and Osteoarthritis Outcome Score (KOOS) holds five subscales including: Pain (9 items); other Symptoms (7 items); Activities of Daily Living (ADL, 17 items); Sport and Recreation function (Sport/Rec, 5 items); and knee-related Quality of Life (QoL, 4 items).
Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems)
|
change from baseline up to 12 months
|
the International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC Score) change
Time Frame: change from baseline up to 12 months
|
The International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC) score questionnaire contains 18 items (7 items for symptoms, 1 item for sport activity, 9 items for daily activities, and 1 item for current knee function.)
The total score is transformed to a value on a scale of 0 to 100, with 100 representing the highest knee function and 0 is the worst.
|
change from baseline up to 12 months
|
waist circumstance change
Time Frame: change from baseline up to 12 months
|
waist circumstance (cm)
|
change from baseline up to 12 months
|
systolic blood pressure change
Time Frame: change from baseline up to 12 months
|
systolic blood pressure /mmHg
|
change from baseline up to 12 months
|
diastolic blood pressure change
Time Frame: change from baseline up to 12 months
|
diastolic blood pressure/mmHg
|
change from baseline up to 12 months
|
serum total cholesterol (TC) change
Time Frame: change from baseline up to 12 months
|
serum total cholesterol (TC) (mmol/L)
|
change from baseline up to 12 months
|
serum triglycerides (TG) change
Time Frame: change from baseline up to 12 months
|
serum triglycerides (TG) (mmol/L)
|
change from baseline up to 12 months
|
low-density lipoprotein cholesterol (LDL-C) change
Time Frame: change from baseline up to 12 months
|
serum low-density lipoprotein cholesterol (LDL-C) (mmol/L)
|
change from baseline up to 12 months
|
high-density lipoprotein cholesterol (HDL-C) change
Time Frame: change from baseline up to 12 months
|
serum high-density lipoprotein cholesterol (HDL-C) (mmol/L)
|
change from baseline up to 12 months
|
fast blood glucose(FBG) change
Time Frame: change from baseline up to 12 months
|
serum fast blood glucose(FBG) (mmol/L)
|
change from baseline up to 12 months
|
Body mass index change
Time Frame: change from baseline up to 12 months
|
Body mass index(BMI) weight/height square (kg/㎡)
|
change from baseline up to 12 months
|
Kellgren-Lawrence (K/L) grade change
Time Frame: change from baseline up to 12 months
|
Kellgren-Lawrence (K/L) grade
|
change from baseline up to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pain score change
Time Frame: change from baseline up to 12 months
|
The minimum is 0 points, the maximum is 4 points, from extreme knee problems to no knee problems.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
|
change from baseline up to 12 months
|
symptoms score change
Time Frame: change from baseline up to 12 months
|
The minimum is 0 points, the maximum is 4 points, from extreme knee problems to no knee problems.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
|
change from baseline up to 12 months
|
activities of daily living score change
Time Frame: change from baseline up to 12 months
|
The minimum is 0 points, the maximum is 4 points, from extreme knee problems to no knee problems.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula
|
change from baseline up to 12 months
|
function in sport and recreation score change
Time Frame: change from baseline up to 12 months
|
The minimum is 0 points, the maximum is 4 points, from extreme knee problems to no knee problems.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula
|
change from baseline up to 12 months
|
knee related quality of life score change
Time Frame: change from baseline up to 12 months
|
The minimum is 0 points, the maximum is 4 points, from extreme knee problems to no knee problems.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula
|
change from baseline up to 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2020
Primary Completion (Anticipated)
August 2, 2023
Study Completion (Anticipated)
August 10, 2023
Study Registration Dates
First Submitted
December 2, 2022
First Submitted That Met QC Criteria
December 16, 2022
First Posted (Actual)
December 19, 2022
Study Record Updates
Last Update Posted (Actual)
March 14, 2023
Last Update Submitted That Met QC Criteria
March 11, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- ShenzhenPH meniscus001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Medial Meniscus Tears
-
Smith & Nephew, Inc.CompletedMeniscus Lesion | Meniscus Disorder | Knee Medial Meniscus Tears | Meniscus; Rupture, Bucket HandleUnited States
-
eMKa MED Medical CenterWroclaw Medical UniversityRecruitingMeniscus; Detachment, Current Injury | Detachment | Medial Mensical Tear | Medial Meniscus Knee InjuryPoland
-
Central Jutland Regional HospitalUniversity of AarhusCompletedKnee Injuries | Knee; Injury, Meniscus (Lateral) (Medial)Denmark
-
Eskisehir Osmangazi UniversityThe Scientific and Technological Research Council of TurkeyRecruitingArthralgia | Knee Injuries | Meniscus; Degeneration | Knee Pain Swelling | Meniscus Lesion | Meniscus Tear | Knee; Injury, Meniscus (Lateral) (Medial) | Meniscus; Laceration | Meniscus Injury, TibialTurkey
-
Austin V StoneTerminatedAnterior Cruciate Ligament Tear | Tibial Meniscus Injuries | Tibial Meniscus Tears | Tibial Meniscus, TornUnited States
-
The Leeds Teaching Hospitals NHS TrustUnknown
-
Orthox LimitedUniversity of Bristol; Avon Orthopaedic Centre, North Bristol NHS Trust, Bristol...TerminatedOther Tear of Medial Meniscus, Current InjuryUnited Kingdom
-
Assiut UniversityCompletedMedial Meniscus, Posterior Horn DerangementEgypt
-
Wake Forest University Health SciencesCompletedPostoperative Analgesia | Medial Unicompartmental Knee ArthroplastyUnited States
Clinical Trials on physical therapy
-
Riphah International UniversityCompleted
-
Mayo ClinicDePuy OrthopaedicsCompleted
-
International Hellenic UniversityNot yet recruitingChronic Pain | Neuropathic Pain | Cognitive Therapy
-
Universidad de ZaragozaCompletedPlagiocephaly | Plagiocephaly, Nonsynostotic | Plagiocephaly, PositionalSpain
-
Riphah International UniversityCompletedAdhesive Capsulitis of ShoulderPakistan
-
Ragaee Saeed MahmoudRecruiting
-
Iuliu Hatieganu University of Medicine and PharmacyCompletedParkinson DiseaseRomania
-
Universidad Rey Juan CarlosCompleted
-
University of AarhusCompleted